Accrued Deposit Liability, Future Incremental Costs

No definition available.

Name:	novn_AccruedDepositLiabilityFutureIncrementalCosts
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The maximum aggregate value of potential milestone payments receivable under the license agreement upon achievement of various commercial milestones.

+ References

No definition available.

+ Details

Name:	novn_AggregateCommercialMilestonePaymentsPotentiallyReceivableUnderLicenseAgreement
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Aggregate non-contingent milestone payments that become payable upon the earlier occurrence of specified fixed dates in the future or the achievement of specified milestone events.

+ References

No definition available.

+ Details

Name:	novn_AggregateNonContingentMilestonePaymentsPotentiallyReceivableUnderLicenseAgreement
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaboration Agreement, Contra Expense

+ References

No definition available.

+ Details

Name:	novn_CollaborationAgreementContraExpense
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative arrangements transactions.

+ References

No definition available.

+ Details

Name:	novn_CollaborativeArrangementsTransactionsLineItems
Namespace Prefix:	novn_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Estimated performance period for revenue recognition

+ References

No definition available.

+ Details

Name:	novn_EstimatedPerformancePeriod
Namespace Prefix:	novn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum amount of funding for potential research activities conducted by the Company per the agreement.

+ References

No definition available.

+ Details

Name:	novn_MaximumPotentialAmountOfResearchActivityCostsPaidPerAgreement
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Monetary value of phase I trial milestone payment pursuant to the terms of the license agreement.

+ References

No definition available.

+ Details

Name:	novn_MonetaryValuePhaseITrialMilestonePaymentTermUnderLicenseAgreement
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash received upon achievement of non contingent milestone pursuant to the terms of the license agreement.

+ References

No definition available.

+ Details

Name:	novn_NonContingentMilestonePaymentReceivedUnderLicenseAgreement
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Upfront payment receivable from licensee per license agreement.

+ References

No definition available.

+ Details

Name:	novn_UpfrontLicenseAgreementPaymentReceivable
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Installment payment of upfront payment receivable from licensee per license agreement.

+ References

No definition available.

+ Details

Name:	novn_UpfrontLicenseAgreementPaymentReceivableInstallment
Namespace Prefix:	novn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash received from licensees for license fees during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_ProductOrServiceAxis=novn_LicenseAndCollaborationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=novn_SatoPharmaceuticalCompanyLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=novn_MC2AgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License and Collaboration Revenues - Narrative (Details) ¥ in Millions										3 Months Ended			9 Months Ended
	Nov. 07, 2019 USD ($)	Nov. 07, 2019 JPY (¥)	Mar. 14, 2019 USD ($)	Mar. 14, 2019 JPY (¥)	Oct. 23, 2018 USD ($)	Oct. 23, 2018 JPY (¥)	Jan. 19, 2017 USD ($)	Jan. 19, 2017 JPY (¥)	Jan. 12, 2017 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 JPY (¥)	Feb. 28, 2022 USD ($)	Feb. 28, 2022 JPY (¥)	May 20, 2021 USD ($)	May 20, 2021 JPY (¥)	Feb. 14, 2019 JPY (¥)	Dec. 31, 2018 USD ($)	Dec. 31, 2018 JPY (¥)	Oct. 05, 2018 JPY (¥)
Collaborative Arrangements Transactions [Line Items]
Estimated performance period												10 years
License and collaboration revenues
Collaborative Arrangements Transactions [Line Items]
Revenue from contract with customer										$ 492,000	$ 680,000		$ 2,010,000	$ 2,174,000
Amended Sato Agreement
Collaborative Arrangements Transactions [Line Items]
Maximum Potential Amount Of Research Activity Costs Paid Per Agreement									$ 1,000,000
Proceeds from License Fees Received	$ 4,554,000	¥ 500	$ 4,460,000	¥ 500	$ 2,224,000	¥ 250	$ 10,813,000	¥ 1,250
Aggregate Phase 1 trial milestone payment term under license agreement																					$ 2,162,000	¥ 250
Upfront payment receivable \| ¥																							¥ 1,250
Upfront payment installments \| ¥																				¥ 500			250
Aggregate becoming payable upon earlier of specified future dates or achievement of milestone events \| ¥																							1,000
Aggregate commercial milestone payments potentially receivable under license agreement \| ¥															¥ 500								¥ 3,900
Milestone payment received																$ 4,323,000	¥ 500	$ 4,572,000	¥ 500
Amended Sato Agreement \| License and collaboration revenues
Collaborative Arrangements Transactions [Line Items]
Revenue from contract with customer										646,000	$ 680,000		1,939,000	$ 2,174,000
MC2 Agreement \| License and collaboration revenues
Collaborative Arrangements Transactions [Line Items]
Contra expense										2,918,000			6,081,000
Accrued deposit liability										$ 2,799,000			$ 2,799,000